title: Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma.
abstract: OBJECTIVE
  To determine whether serum interleukin-18 (IL-18) levels correlated with clinicopathologic features and prognosis in patients with hepatocellular carcinoma (HCC).
  
  
  METHODS
  Serum IL-18, IL-6 and IL-12 levels were measured by enzyme-linked immunosorbent assay (ELISA) from 70 patients with HCC and 10 healthy controls.
  
  
  RESULTS
  Serum IL-18, IL-6 and IL-12 levels of patients with HCC were significantly higher that those of the controls. The levels of IL-18 correlated significantly with the presence of venous invasion and advanced tumor stages classified by Okuda's criteria. Patients with high serum IL-18 levels (>= 10(5) pg/mL) had a poorer survival than those with low serum IL-18 levels (< 10(5) pg/mL) (4 and 11 mo, respectively, P = 0.015). Multivariate analyses showed that serum IL-18 level, but not IL-6 and IL-12 levels, was a significant and independent prognostic factor of survival.
  
  
  CONCLUSIONS
  These findings demonstrate that serum IL-8 may a useful biological marker of tumor invasiveness and an independent prognostic factor of survival for patients with HCC. Thus, the detailed mechanisms of IL-18 involving in tumor progression should be further investigated.
authors: Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
authors: Pisit
authors: P
authors: Tangkijvanich
authors: Duangporn
authors: D
authors: Thong-Ngam
authors: Varocha
authors: V
authors: Mahachai
authors: Apiradee
authors: A
authors: Theamboonlers
authors: Yong
authors: Y
authors: Poovorawan
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000175:diagnosis*; D018450:Disease Progression; D005260:Female; D006801:Humans; D018664:Interleukin-12 / Q000097:blood; D020382:Interleukin-18 / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood; D008113:Liver Neoplasms / Q000097:blood / Q000175:diagnosis*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016019:Survival Analysis
chemical_list: D014408:Biomarkers, Tumor; D020382:Interleukin-18; D015850:Interleukin-6; D018664:Interleukin-12
references: J Immunol Methods. 1998 Nov 1;220(1-2):1-17
references: 9839921
references: Int J Cancer. 2002 Apr 20;98(6):873-8
references: 11948465
references: Am J Clin Oncol. 2003 Aug;26(4):416-21
references: 12902898
references: Gastroenterology. 2004 Nov;127(5 Suppl 1):S5-S16
references: 15508102
references: Hepatol Res. 2003 Dec;27(4):309-314
references: 14662119
references: Br J Cancer. 1995 Feb;71(2):354-6
references: 7841052
references: Methods. 1999 Sep;19(1):121-32
references: 10525448
references: Cancer Res. 1992 Jun 15;52(12):3317-22
references: 1596890
references: J Leukoc Biol. 2003 Feb;73(2):213-24
references: 12554798
references: Clin Cancer Res. 2001 Nov;7(11):3504-9
references: 11705869
references: Int J Cancer. 1999 Jun 21;84(3):326-30
references: 10371355
references: Clin Immunol Immunopathol. 1998 Jan;86(1):11-5
references: 9434792
references: Hepatogastroenterology. 2002 Nov-Dec;49(48):1625-31
references: 12397750
references: J Clin Invest. 1998 Mar 15;101(6):1441-52
references: 9502787
references: Blood. 1989 Jul;74(1):1-10
references: 2473791
references: Annu Rev Immunol. 2001;19:423-74
references: 11244043
references: Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5996-6001
references: 14676125
references: Eur J Pharmacol. 2004 Oct 1;500(1-3):63-71
references: 15464021
references: Cancer Res. 2000 Sep 1;60(17):4838-44
references: 10987295
references: Immunol Lett. 1990 Mar-Apr;24(1):1-9
references: 2197219
references: World J Gastroenterol. 2002 Apr;8(2):193-9
references: 11925590
references: Eur Cytokine Netw. 2000 Mar;11(1):15-26
references: 10705295
references: Int J Cancer. 2006 Feb 1;118(3):564-70
references: 16108033
references: Cancer Lett. 2004 Mar 18;205(2):207-14
references: 15036653
references: Clin Cancer Res. 2000 Jul;6(7):2702-6
references: 10914713
references: Int Rev Immunol. 1998;16(5-6):683-704
references: 9646182
references: Lancet. 2001 Feb 17;357(9255):539-45
references: 11229684
references: Gastroenterology. 2004 Nov;127(5 Suppl 1):S126-32
references: 15508076
references: Immunol Lett. 2002 Dec 3;84(3):163-72
references: 12413732
references: Acta Haematol. 2000;103(3):162-4
references: 10940655
references: J Clin Immunol. 1999 Jan;19(1):1-11
references: 10080100
references: Cancer. 2001 Oct 15;92(8):2050-5
references: 11596019
references: Surg Today. 2004;34(12):1014-9
references: 15580384
references: Annu Rev Immunol. 1998;16:495-521
references: 9597139
references: Cancer Res. 1996 Feb 1;56(3):467-70
references: 8564954
references: Ann Surg. 2000 Apr;231(4):552-8
references: 10749617